Galera Therapeutics, Inc.(GRTX)
$17.15—
Galera Therapeutics, Inc.(GRTX)
NASDAQ
$17.15—
Analyst Sentiment
Wall St. Consensus
Buy9 analysts·Limited coverage
67
Score
6 Buy (67%)3 Hold (33%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
667%
Hold
333%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
No analyst price targets available for GRTX
Analyst coverage may not be available for this symbol
Earnings & Revenue Estimates
Raw consensus estimates (low / average / high) from covering analysts.
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| EBITDA Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| EBIT Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| Net Income Avg | $-76M | $-70M | $-70M | $-56M | $-49M | $-52M | $-50M | $-38M |
| Low | $-76M | $-70M | $-70M | $-56M | $-49M | $-52M | $-50M | $-38M |
| High | $-76M | $-70M | $-70M | $-56M | $-49M | $-52M | $-50M | $-38M |
| EPS Avg | $-154.76 | $-142.55 | $-141.01 | $-114.27 | $-98.46 | $-104.95 | $-101.42 | $-76.46 |
| Low | $-154.76 | $-142.55 | $-141.01 | $-114.27 | $-98.46 | $-104.95 | $-101.42 | $-76.46 |
| High | $-154.76 | $-142.55 | $-141.01 | $-114.27 | $-98.46 | $-104.95 | $-101.42 | $-76.46 |
| Analysts (Rev / EPS) | — / 1 | — / 1 | — / 1 | — / 1 | — / 1 | — / 1 | — / 1 | — / 1 |
Earnings Surprises
Recent Analyst Actions
No recent analyst actions